subcutaneously to the outside of a vein, fistula or graft, just beneath the skin. Their design and technology ensure repetitive vessel puncturing in the exact same spot. JEM’s attachment and internal design will prevent hematomas, thromboses and stenosis. JEM is projected to reduce the rate of clinical complications and reduce patient morbidity and mortality by providing safer venous access, while lowering healthcare costs.

Particularly in dialysis patients who require repetitive access to fistulas where damage from pseudoaneurysms and hematomas may lead to increased morbidity and mortality. Access for Life's JEM patented chamber, affixed to the vessel wall, will avoid these complications and in cancer patients, its placement on an upper arm vein avoids chest wall complications. It's suitable for all vascular access patients.